[Federal Register Volume 79, Number 106 (Tuesday, June 3, 2014)]
[Notices]
[Page 31986]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2014-12795]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Importer of Controlled Substances; Notice of Registration; 
Hospira

    By Notice dated December 16, 2013, and published in the Federal 
Register on January 2, 2014, 79 FR 151, Hospira, 1776 North Centennial 
Drive, McPherson, Kansas 67460-1247, made application by renewal to the 
Drug Enforcement Administration (DEA) to be registered as an importer 
of Remifentanil (9739), a basic class of controlled substance listed in 
schedule II.
    The company plans to import Remifentanil for use in dosage form 
manufacturing.
    No comments or objections have been received. The DEA has 
considered the factors in 21 U.S.C. 823(a) and 952(a) and determined 
that the registration of Hospira to import the basic class of 
controlled substance is consistent with the public interest and in 
accordance with United States obligations under international treaties, 
conventions, or protocols in effect on May 1, 1971. The DEA has 
investigated Hospira to ensure that the company's registration is 
consistent with the public interest. The investigation has included 
inspection and testing of the company's physical security systems, 
verification of the company's compliance with state and local laws, and 
a review of the company's background and history.
    Therefore, pursuant to 21 U.S.C. 952(a) and 958(a), and in 
accordance with 21 CFR 1301.34, the above named company is granted 
registration as an importer of the basic class of controlled substance 
listed.

    Dated: May 28, 2014.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 2014-12795 Filed 6-2-14; 8:45 am]
BILLING CODE 4410-09-P